Biomarker Of Tamoxifen Resistance In Breast Cancer Identified
New research led by the University of Manchester in the UK has found a biomarker or molecular "flag" in women with breast cancer who do not repond, or who have become resistant, to treatment with the hormone drug tamoxifen...